These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2766925)

  • 1. Insulin resistance.
    Diabetes Metab Rev; 1989 Sep; 5(6):475-530. PubMed ID: 2766925
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium antagonists and insulin resistance].
    Higashi Y; Yoshizumi M
    Clin Calcium; 2005 Oct; 15(10):1675-80. PubMed ID: 16199914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, HIV infection, and anti-HIV therapies.
    Taiwo BO
    AIDS Read; 2005 Apr; 15(4):171-6, 179-80. PubMed ID: 15844237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptors and syndromes of insulin resistance.
    Kahn CR
    Diabetes Care; 1982; 5 Suppl 1():98-101. PubMed ID: 6765124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is mitochondrial dysfunction a cause of insulin resistance?
    Turner N; Heilbronn LK
    Trends Endocrinol Metab; 2008 Nov; 19(9):324-30. PubMed ID: 18804383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and essential hypertension: mechanisms and clinical implications.
    Morris AD; Connell JM
    Am J Med Sci; 1994 Feb; 307 Suppl 1():S47-52. PubMed ID: 8141165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial stiffness and insulin resistance.
    Westerbacka J; Yki-Järvinen H
    Semin Vasc Med; 2002 May; 2(2):157-64. PubMed ID: 16222607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in a patient with ovarian stromal hyperthecosis and the hyperandrogenism, insulin resistance and acanthosis nigricans syndrome. Report of a case with a possible endogenous ovarian factor.
    Mantzoros CS; Lawrence WD; Levy J
    J Reprod Med; 1995 Jun; 40(6):491-4. PubMed ID: 7650669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular and molecular mechanisms of insulin resistance].
    Seböková E; Klimes I; Stolba P
    Vnitr Lek; 1995 Feb; 41(2):76-83. PubMed ID: 7725644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals.
    Reaven G
    Endocrinol Metab Clin North Am; 2004 Jun; 33(2):283-303. PubMed ID: 15158520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective treatments for insulin resistance: trim the fat and douse the fire.
    Evans JL; Youngren JF; Goldfine ID
    Trends Endocrinol Metab; 2004 Nov; 15(9):425-31. PubMed ID: 15519889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peritoneal dialysis and insulin resistance in patients with chronic kidney disease due to nondiabetic nephropathy].
    Wesołowski P; Saracyn M; Nowak Z; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):359-63. PubMed ID: 18634374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of insulin resistance.
    Bell PM
    Diabet Med; 1996 Jun; 13(6):504-9. PubMed ID: 8799651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance: definition and treatment.
    Roffman DS; Wiser TH
    Am J Hosp Pharm; 1980 Aug; 37(8):1105-10. PubMed ID: 6773414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing insulin resistance in Type 1 diabetes.
    Pang TT; Narendran P
    Diabet Med; 2008 Sep; 25(9):1015-24. PubMed ID: 19183305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cardiovascular risk: early identification of insulin resistance.
    Fortson J; Howe L; Harmon C; Sherrill WW
    J Am Acad Nurse Pract; 2008 Jun; 20(6):319-25. PubMed ID: 18588659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin resistance. Frequently administration errors are the source].
    Rendschmidt T; Lüddeke HJ; Renner R; Hepp KD
    MMW Fortschr Med; 2000 May; 142(21):38-41. PubMed ID: 10872293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: hepatic steatosis and insulin resistance.
    Lonardo A; Lombardini S; Ricchi M; Scaglioni F; Loria P
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():64-70. PubMed ID: 16225477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of troglitazone in treating the insulin resistance syndrome.
    Granberry MC; Schneider EF; Fonseca VA
    Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is insulin resistance atherogenic? A review of the evidence.
    Ferrannini E; Iozzo P
    Atheroscler Suppl; 2006 Aug; 7(4):5-10. PubMed ID: 16824807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.